Christopher M Starr insider trades

Open-market stock purchases and sales by Christopher M Starr, Director at Monopar Therapeutics, from SEC Form 4 filings since Mar 9, 2010.

Recent trades

DateStockTradeValue
Oct 1, 2026MNPR Monopar TherapeuticsSold$362K
Oct 1, 2026MNPR Monopar TherapeuticsSold$234K
Oct 1, 2026MNPR Monopar TherapeuticsSold$63.7K
Oct 1, 2026MNPR Monopar TherapeuticsBought (not open market)$42
Oct 1, 2026MNPR Monopar TherapeuticsBought (not open market)—
Dec 2, 2025MNPR Monopar TherapeuticsBought (not open market)—

Companies traded

  • MNPR Monopar Therapeutics: 4 sales, last Oct 1, 2026
  • NONE Monopar Therapeutics: other filings, last Aug 9, 2018
  • RPTP Raptor Pharmaceutical Corp: 37 sales, last Oct 25, 2016

Get free alerts when Christopher M Starr files a new trade →